Vitamin A
FDA-approved product (capsule, oral), marketed as Aquasol A, Vitamin A.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Acne
- Eye disease
- Nasal congestion
Indications ChEMBL records as approved, from FDA and DailyMed labels.
- WHO therapeutic group
- Vitamin a, plain; Retinoids for topical use in acne; Other nasal preparations; Other ophthalmologicals
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Vitamin A, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA20.2% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli32.2% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae13.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis36.5% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Vitamin A with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Mefloquine HydrochlorideExisting use: Malaria, Plasmodium falciparum malaria, Plasmodium vivax malaria81.8% AI-predicted activityagainst M. tuberculosisLab records exist8 registered studies
- KetoconazoleExisting use: Adrenal gland disease, Blastomycosis, Cushing syndrome and 3 more81.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- LevoketoconazoleExisting use: Adrenal gland disease, Adrenal gland hyperfunction, Cushing syndrome81.2% AI-predicted activityagainst M. tuberculosis6 registered studies
- Fluphenazine DecanoateExisting use: Mental or behavioural disorder, Psychosis80.7% AI-predicted activityagainst M. tuberculosis4 registered studies
- Fluphenazine EnanthateExisting use: Mental or behavioural disorder, Psychosis80.7% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- NifurtimoxExisting use: American trypanosomiasis, Chagas disease, Leishmaniasis and 1 more78.4% AI-predicted activityagainst M. tuberculosis19 registered studies
- Fluphenazine HydrochlorideExisting use: Mental or behavioural disorder, Psychosis77.8% AI-predicted activityagainst M. tuberculosis5 registered studies
- NitazoxanideExisting use: Amebiasis, Diarrhea77.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- TopiramateExisting use: Epilepsy, Lennox-Gastaut syndrome, Migraine disorder and 1 more77.4% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- TrabectedinExisting use: Cancer, Dedifferentiated liposarcoma, Leiomyosarcoma and 7 more76.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Chlorpromazine HydrochlorideExisting use: Conduct disorder, Mental or behavioural disorder, Nausea and vomiting and 3 more75.0% AI-predicted activityagainst M. tuberculosis33 registered studies
- ProchlorperazineExisting use: Anxiety disorder, Nausea and vomiting, Psychosis and 1 more74.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL
NCT04175587 · start 2019-12-01
Registered record
- Registry ID
- NCT04175587
- Conditions
- Acute Promyelocytic Leukaemia
- Interventions
- Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2019-12-01
- Completion
- 2023-08-31
- Enrolment
- 109
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Promyelocytic LeukaemiaInterventionCompound Realgar-Indigo Naturalis Formula Plus Retinoic AcidPhasePhase 3Registry statusUnknownSynergy of Exercise and Nutrition in Preventing and Treating Frailty
NCT06975540 · start 2019-10-14
Registered record
- Registry ID
- NCT06975540
- Conditions
- Frail Elderly
- Interventions
- Multidomain physical exercise
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-10-14
- Completion
- 2022-07-29
- Enrolment
- 47
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionFrail ElderlyInterventionMultidomain physical exercisePhaseNot applicableRegistry statusCompleted"Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy"
NCT07476508 · start 2019-10-10
Registered record
- Registry ID
- NCT07476508
- Conditions
- Meniscus Lesion; Knee Injuries; Medial Meniscus Tear
- Interventions
- Standard Postoperative Rehabilitation Protocol; Oral Chondroitin Sulfate (Flextrum); ntra-articular Hyaluronic Acid Injection (Biolevox)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-10-10
- Completion
- 2022-03-31
- Enrolment
- 290
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMeniscus Lesion; Knee Injuries; Medial Meniscus TearInterventionStandard Postoperative Rehabilitation Protocol; Oral Chondroitin Sulfate (Flextrum); ntra-articular Hyaluronic Acid Injection (Biolevox)PhaseNot applicableRegistry statusCompletedVitamin D Oral Replacement in Asthma
NCT03686150 · start 2019-01-30
Registered record
- Registry ID
- NCT03686150
- Conditions
- Asthma; Vitamin D Deficiency; Pediatric Obesity
- Interventions
- Vitamin D3 oral regimen
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-01-30
- Completion
- 2021-09-30
- Enrolment
- 112
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAsthma; Vitamin D Deficiency; Pediatric ObesityInterventionVitamin D3 oral regimenPhaseNot applicableRegistry statusCompletedLongitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients
NCT03610139 · start 2018-05-21
Registered record
- Registry ID
- NCT03610139
- Conditions
- Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Clinically Isolated Syndrome; Clinically Isolated Syndrome, CNS Demyelinating; Vitamin D3 Deficiency
- Interventions
- Vitamin D3
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2018-05-21
- Completion
- 2022-12-31
- Enrolment
- 162
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMultiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Clinically Isolated Syndrome; Clinically Isolated Syndrome, CNS Demyelinating +1 moreInterventionVitamin D3PhaseNot applicableRegistry statusUnknownEffect of Vitamin C on Collagen Production in Comparison to Hereditary Gingival Fibromatosis: Histopathological Study
NCT07043985 · start 2018-01-03
Registered record
- Registry ID
- NCT07043985
- Conditions
- Tissue Modification After Vit c Injection
- Interventions
- biopsy
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2018-01-03
- Completion
- 2025-05-06
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTissue Modification After Vit c InjectionInterventionbiopsyPhaseNot applicableRegistry statusCompletedThe Effect of Vitamin D on Fertility
NCT03890458 · start 2017-05-01
Registered record
- Registry ID
- NCT03890458
- Conditions
- Infertility; Infertility, Female; Vitamin D Deficiency; Vitamin D3 Deficiency
- Interventions
- DEVIT-3
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2017-05-01
- Completion
- 2017-11-30
- Enrolment
- 118
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInfertility; Infertility, Female; Vitamin D Deficiency; Vitamin D3 DeficiencyInterventionDEVIT-3PhasePhase 4Registry statusCompletedThe Impact of Vitamin B12 Deficiency on Infant Gut Microbiota
NCT03365583 · start 2017-03-03
Registered record
- Registry ID
- NCT03365583
- Conditions
- Vitamin B 12 Deficiency
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2017-03-03
- Completion
- 2017-11-03
- Enrolment
- 90
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin B 12 DeficiencyInterventionNot recordedPhaseNot recordedRegistry statusCompleted6 Years Study on Changes in Bone Quality, Bone Turnover and Curve Severity in AIS With and Without Calcium and Vit-D Supplementation
NCT02904421 · start 2016-10
Registered record
- Registry ID
- NCT02904421
- Conditions
- Scoliosis; Vitamin D; Bone
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-10
- Completion
- 2019-11
- Enrolment
- 330
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionScoliosis; Vitamin D; BoneInterventionNot recordedPhaseNot recordedRegistry statusCompletedNicotinamide Riboside and Mitochondrial Metabolism
NCT03951285 · start 2016-05-25
Registered record
- Registry ID
- NCT03951285
- Conditions
- Obesity
- Interventions
- NR in BMI-discordant twins; NR in BMI-concordant twins
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2016-05-25
- Completion
- 2019-05-31
- Enrolment
- 56
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionObesityInterventionNR in BMI-discordant twins; NR in BMI-concordant twinsPhaseNot applicableRegistry statusCompletedEvaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC
NCT03047603 · start 2016-05-01
Registered record
- Registry ID
- NCT03047603
- Conditions
- Hepatocellular Carcinoma
- Interventions
- PIVKA-II
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-05-01
- Completion
- 2019-03-20
- Enrolment
- 4,005
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHepatocellular CarcinomaInterventionPIVKA-IIPhaseNot recordedRegistry statusCompletedAtrial Fibrillation Patient Preference Study
NCT02611635 · start 2016-02-02
Registered record
- Registry ID
- NCT02611635
- Conditions
- Atrial Fibrillation
- Interventions
- VKA: Warfarin (Waran); NOAC: Rivaroxaban (Xarelto, BAY59-7939); NOAC: Dabigatran etexilate; NOAC: Apixaban; NOAC: Edoxaban; NOAC: Lixiana
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-02-02
- Completion
- 2017-02-16
- Enrolment
- 382
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAtrial FibrillationInterventionVKA: Warfarin (Waran); NOAC: Rivaroxaban (Xarelto, BAY59-7939); NOAC: Dabigatran etexilate; NOAC: Apixaban +2 morePhaseNot recordedRegistry statusCompletedRapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial
NCT02452762 · start 2016-01
Registered record
- Registry ID
- NCT02452762
- Conditions
- Hypovitaminosis D
- Interventions
- Vitamin D3; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2016-01
- Completion
- 2018-01
- Enrolment
- 67
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypovitaminosis DInterventionVitamin D3; PlaceboPhasePhase 2Registry statusCompletedCholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
NCT02553447 · start 2015-10-19
Registered record
- Registry ID
- NCT02553447
- Conditions
- Chronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma; Untreated Chronic Lymphocytic Leukemia; Vitamin D Deficiency
- Interventions
- Cholecalciferol; Laboratory Biomarker Analysis
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2015-10-19
- Completion
- 2025-04-12
- Enrolment
- 197
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma; Untreated Chronic Lymphocytic Leukemia; Vitamin D DeficiencyInterventionCholecalciferol; Laboratory Biomarker AnalysisPhaseNot applicableRegistry statusCompletedLong Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
NCT02774226 · start 2015-09
Registered record
- Registry ID
- NCT02774226
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Tetrahydrobiopterin (BH4); Antioxidant Cocktail
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2015-09
- Completion
- 2018-07-30
- Enrolment
- 15
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Obstructive Pulmonary Disease (COPD)InterventionTetrahydrobiopterin (BH4); Antioxidant CocktailPhasePhase 2Registry statusCompleted